8 min listen
Eagle’s Eye View: Your Weekly CV Update From ACC.org (Week of Dec. 22)
Eagle’s Eye View: Your Weekly CV Update From ACC.org (Week of Dec. 22)
ratings:
Length:
8 minutes
Released:
Dec 22, 2021
Format:
Podcast episode
Description
This week’s View looks at differences in results of the REDUCE-IT (Reduction of Cardiovascular Events With Icosapent Ethyl-Intervention Trial) and STRENGTH (Long-Term Outcomes Study to Assess Statin Residual Risk With Epanova in High Cardiovascular Risk Patients With Hypertriglyceridemia) trials and if they can be explained by the active and comparator oils on lipid traits and C-reactive protein (CRP). Dr. Eagle also examines whether traditional CV risk factors are associated with incident ASCVD among those with absent coronary calcium. And finally, Dr. Eagle looks at driving restrictions in those receiving a secondary prevention ICD.
Released:
Dec 22, 2021
Format:
Podcast episode
Titles in the series (94)
Eagle’s Eye View: Day 2 Highlights | TCT 2021: In this special episode of Eagle’s Eye View, Drs. Deepak Bhatt, Roxana Mehran, and George Vetrovec discuss highlights from the hottest clinical trials presented during Day 2 of TCT 2021, including PRAGUE-17 and STOPDAPT-2 Total Cohort. by Eagle's Eye View: Your Weekly CV Update From ACC.org